Breakoutwatch Weekly Summary 09/17/2023

You are receiving this email because you are or were a BreakoutWatch.com subscriber, or have subscribed to our weekly newsletter.
To read this newsletter on the site, click here: Newsletter .

Contents

The newsletter has been absent for a few weeks as I have concentrated on correcting some data problems introduced by a hack of the database. I believe all stock data is now correct and watchlist filters are working again. Next week I depart for 4 weeks on a European vacation but will try to produce this newsletter remotely.

Market Summary

Rising Oil Prices Boost Value Stocks

The major equity indexes finished mixed, with value stocks leading the market as U.S. benchmark West Texas Intermediate oil prices rose above $90 per barrel for the first time since November 2022. Large-cap shares outperformed small-caps. [more...]

Major Index Performance

Dow Jones
Last Close
Wk. Gain NAN %
Yr. Gain NAN %
Trend Up
Dow Jones
S&P 500
Last Close
Wk. Gain NAN %
Yr. Gain NAN %
Trend Down
S&P 500
NASDAQ Comp.
Last Close
Wk. Gain NAN %
Yr. Gain NAN %
Trend Down
NASDAQ Comp.
Russell 2000
Last Close
Wk. Gain NAN %
Yr. Gain NAN %
Trend Down
Russell 2000

Performance by Sector

Sector Wk. Change % Yr. Change % Trend
Consumer Discretionary 1.98 34.3 Up
Consumer Staples 1.19 0.11 Down
Energy 0.82 8.98 Up
Finance 1.47 2.91 Up
Health Care 0.58 -1.61 Down
Industrials 0 11.31 Down
Technology -1.31 37.31 Up
Materials 0.46 6.28 Up
REIT 0.53 -0.44 Up
Telecom 1.29 35.21 Up
Utilities 3.17 -8.95 Up

Breakouts This Week Still Within 5% of Breakout Price (Limit 20 top C Score)

Watchlist Symbol Company Industry C Score* % Gain
*C score is our assessment of a Stock's correlation to CAN SLIM principles. It combines a stock's Technical and Fundamental merits and is expressed as a percentage.

Breakdowns within 5% of Breakdown Price

Watchlist Symbol Company Industry C Score* % Loss
SS SQSP Squarespace, Inc. Software - Infrastructure 65.4 % -4.7 %
SS MRK Merck & Company, Inc. Drug Manufacturers - General 64.6 % -0.4 %
SS SNOW Snowflake Inc. Software - Application 57.2 % -1.7 %
*C score is our assessment of a Stock's correlation to CAN SLIM principles. It combines a stock's Technical and Fundamental merits and is expressed as a percentage.

Cup and Handle Chart of the Week

Aug. 16, 2023 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced the achievement of First-Patient-In for the company-sponsored Phase 2 clinical trial evaluating darovasertib as neoadjuvant and adjuvant therapy in primary uveal melanoma (UM) patients.